Composition
Each ml contains:
Tilmicosin......300mg

Indication
This injection is indicated for the treatment of respiratory infections in cattle and sheep associated with Mannheimia haemolytica, Pasteurella spp and other
tilmicosin-susceptible micro-organisms, and for the treatment of ovine mastitis associated with Staphylococcus aureus and Mycoplasma spp. Additional
indications include the treatment of interdigital necrobacillosis in cattle (bovine pododermatitis, foul in the foot) and ovine footrot.

Dosage and Administration
For subcutaneous injection:
Cattle – pneumonia : 1 ml per 30 kg body weight (10 mg/kg).
Cattle – interdigital necrobacillosis : 0.5 ml per 30 kg body weight (5 mg/kg).
Sheep – pneumonia and mastitis : 1 ml per 30 kg body weight (10 mg/kg).
Sheep – footrot : 0.5 ml per 30 kg body weight (5 mg/kg).

Side Effects
Hypersensitivity or resistance to tilmicosin.
Occasionally, a soft diffuse swelling may occur at the injection site which subsides without further treatment. The acute manifestations of multiple injections
of large subcutaneous doses (150 mg/kg) in cattle included moderate electrocardiographic changes accompanied by mild focal myocardial necrosis, marked
injection site oedema, and death. Single subcutaneous injections of 30 mg/kg in sheep produced increased respiration rate, and at higher levels (150 mg/kg)
ataxia, lethargy and drooping of the head.

Contraindications
Administration to porcine or caprine species, to cattle producing milk for human consumption or to lambs weighing 15 kg or less.
Do not use in lactating animals. During pregnancy, use only after a risk/benefit assessment by a veterinarian. 
Do not use in heifers within 60 days of calving.
Do not use together with adrenalin or β-adrenergic antagonists such as propranolol.

Withdrawal Time
For meat:
Cattle : 60 days.
Sheep : 42 days.
For Milk:
Sheep : 15 days.

Storage and Expired Time
Tightly sealed and store below 30℃，avoid direct sunlight.
3 years

Packing
100ml

Concentration
30%